SCHEMBL794539

SCHEMBL794539

C[C@@H](CO)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111181 1.00
SCHEMBL2499904 1.00
Methyl Alcohol SCHEMBL25212727 0.97
Ammonia Solution, Strong SCHEMBL28590964 0.97
SCHEMBL10686177 0.94 TSHR (0.55)
Dimethylamine SCHEMBL7886857 0.91 TSHR (0.52)
Methoxymethane SCHEMBL9576631 0.91 TSHR (0.52)
1,4-Butanediol SCHEMBL28034679 0.91 TSHR (0.52)
SCHEMBL6706837 0.90 TSHR (0.50)
SCHEMBL2380118 0.88 TSHR (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4703476-A1 PROCESS FOR THE PREPARATION OF OPTICALLY PURE ALKYL DIOLS AND DERIVATIVES THEREOF Technische Universität Graz (AT) 2026-03-04 EP disclosed
EP-2735562-B2 Estrogen receptor modulators and uses thereof SERAGON PHARMACEUTICALS INC (US) 2023-11-15 EP disclosed
EP-3303326-B1 HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF HOFFMANN LA ROCHE (CH) 2020-12-16 EP disclosed
CN-107531722-B Heterocyclic estrogen receptor modulators and uses thereof 豪夫迈·罗氏有限公司 2020-07-17 CN disclosed
US-10053451-B2 Heterocyclic estrogen receptor modulators and uses thereof GENENTECH, INC. (US) 2018-08-21 US disclosed
EP-3303326-A1 HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF H. Hoffnabb-La Roche Ag (CH) 2018-04-11 EP disclosed
US-9868704-B2 Estrogen receptor modulators and uses thereof GENENTECH, INC. (US) 2018-01-16 US disclosed
US-9868704-B2 Estrogen receptor modulators and uses thereof GENENTECH, INC. (US) 2018-01-16 US disclosed
EP-3205648-A1 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF Seragon Pharmaceuticals, Inc. (US) 2017-08-16 EP disclosed
EP-3205648-A1 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF Seragon Pharmaceuticals, Inc. (US) 2017-08-16 EP disclosed
US-20020110651-A1 Optical laminate NIPPON MITSUBISHI OIL CORPORATION 2002-08-15 US disclosed
US-20020075431-A1 Reflection-type liquid crystal display device NIPPON MITSUBISHI OIL CORPORATION 2002-06-20 US disclosed
EP-1211549-A1 REFLECTION LIQUID CRYSTAL DISPLAY DEVICE Nippon Mitsubishi Oil Corporation (JP) 2002-06-05 EP disclosed
EP-1203968-A1 OPTICAL LAMINATE Nippon Mitsubishi Oil Corporation (JP) 2002-05-08 EP disclosed
US-5456867-A Viewing angle compensator for liquid crystal display NIPPON OIL COMPANY, LIMITED (JP) 1995-10-10 US disclosed
EP-0529813-A2 Compensator for a liquid crystal display Nippon Oil Co., Ltd. (JP) 1993-03-03 EP disclosed
US-4902818-A Process for the manufacture of optically active compounds HOFFMANN-LA ROCHE INC. (US) 1990-02-20 US disclosed
EP-0104376-B1 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE AMINES AND ENAMINES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-05-06 EP disclosed
US-4578462-A Process for the manufacture of optically active compounds HOFFMANN-LA ROCHE INC. (US) 1986-03-25 US disclosed
EP-0104376-A2 Process for the preparation of optically active amines and enamines F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-04-04 EP disclosed